What's breaking now, across thousands of outlets.
MUNICH — Novartis is to kick off a Phase 3 trial to see whether its anti–IL‑6 antibody can prevent cardiovascular (CV) events in people with elevated CV risk by reducing inflammation, despite the failure of ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
The National Assembly Departmental Committee on Health has urged more Kenyans registered under the Social Health Authority (SHA) to make regular contributions, saying registration alone is not enough…
Aurobindo Pharma on Friday said a US Food and Drug Administration (US FDA) inspection at an active pharmaceutical ingredient (API) manufacturing facility operated by its wholly owned subsidiary…
Ophthalmologists point out that at a time when Keralam has been expanding facilities for corneal transplantation in public health institutions, the focus should be on developing robust Hospital Cornea…
KUALA LUMPUR: Conjoined twin Muhammad Rosli has been confirmed dead at Hospital Canselor Tuanku Muhriz UKM here about 10.45am today.
Atherosclerosis, the process underlying most cardiovascular diseases, begins long before the first symptoms appear. An international study shows that the disease can already be detected in apparently…
BUNIA, Congo (AP) -- The fastest-growing Ebola outbreak in history has spread to two new health zones in eastern Congo, with a total of 60 now affecte
